Completed PHASE3 INTERVENTIONAL NCT01046617

Lactobacillus Reuteri for the Treatment of Infantile Colic: (LRTIC)

Lactobacillus Reuteri (DSM 17938) for the Treatment of Infantile Colic: a Randomized Double-blind Placebo Controlled Trial

Sponsor: Medical University of Warsaw

Conditions Crying Infantile Colic

Interventions Lactobacillus reuteri (DSM 17938)

Updated 5 times since 2017 Last updated: Jun 4, 2012 Started: Dec 31, 2009 Primary completion: Apr 30, 2012 Completion: Apr 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Crying and Infantile Colic, this trial is completed. The trial is conducted by Medical University of Warsaw and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Warsaw

Data source: Medical University of Warsaw

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Warsaw, Poland